NEOPLASMS, HEAD AND NECK
Clinical trials for NEOPLASMS, HEAD AND NECK explained in plain language.
Never miss a new study
Get alerted when new NEOPLASMS, HEAD AND NECK trials appear
Sign up with your email to follow new studies for NEOPLASMS, HEAD AND NECK, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo therapy shows promise against HPV-driven head and neck cancer
Disease control CompletedThis study tested a combination of two immunotherapy drugs, PDS0101 and pembrolizumab, in 95 adults with a type of head and neck cancer linked to HPV16 that had returned or spread. The goal was to see if the combination could shrink tumors and improve survival. Participants had t…
Matched conditions: NEOPLASMS, HEAD AND NECK
Phase: PHASE2 • Sponsor: PDS Biotechnology Corp. • Aim: Disease control
Last updated May 17, 2026 04:00 UTC
-
Immunotherapy shows promise in shrinking head and neck tumors before surgery
Disease control CompletedThis study tested whether giving the immunotherapy drug pembrolizumab (MK-3475) before standard surgery could help prevent head and neck cancer from coming back. It included 67 adults with advanced, surgically removable head and neck cancer. The main goal was to see if the drug c…
Matched conditions: NEOPLASMS, HEAD AND NECK
Phase: PHASE2 • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated May 13, 2026 16:02 UTC